VARIAN ASSOCIATES INC /DE/
10-Q, 1994-05-12
ELECTRONIC COMPONENTS & ACCESSORIES
Previous: HARRIS CORP /DE/, 10-Q, 1994-05-12
Next: WESBANCO INC, 10-Q, 1994-05-12



<PAGE>   1
                      SECURITIES AND EXCHANGE COMMISSION
                           Washington, D.C.  20549
              
                                   FORM 10-Q


  (Mark One)

     X       QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE
    ___                 SECURITIES EXCHANGE ACT OF 1934
                  For the quarterly period ended April 1, 1994

                                       OR
    
    ___     TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE
                        SECURITIES EXCHANGE ACT OF 1934
               For the transistion period from _______ to _______

                         Commission File Number: 1-7598

              Exact name of registrant as specified in it charter:
                            VARIAN ASSOCIATES, INC.

<TABLE>
                 <S>                                         <C>
                 State or other jurisdiction of              IRS Employer
                 incorporation or organization:           Identification No.:
                            DELAWARE                          94-2359345
</TABLE>

                    Address of principal executive offices:
               3050 Hansen Way, Palo Alto, California  94304-1000

                      Telephone No., including area code:
                                 (415) 493-4000

             Securities registered pursuant to Section 12(b)of the Act:

<TABLE>
<CAPTION>
                                                             Name of each exchange         
        Title of each class                                   on which registered
        -------------------                                  --------------------
        <S>                                                  <C>
        Common Stock,                                        New York Stock Exchange
        $1 par value                                         Pacific Stock Exchange

        Preferred Stock                                      New York Stock Exchange
        Purchase Rights                                      Pacific Stock Exchange
</TABLE>


           Securities registered pursuant to Section 12(g)of the Act:
                                      None

        Indicate by check mark whether the registrant (1) has filed all reports
required to be filed by Section 13 or 15(d) of the Securities Exchange Act of
1934 during the preceding 12 months (or for such shorter period registrant was
required to file such reports), and (2) has been subject to such filing
requirements for the past 90 days.  YES   X    NO
                                         ----      ----
                                         
        An index of exhibits filed with this Form 10-Q is located on page 15.

        Indicate the number of shares outstanding of each of the issuer's
classes of common stock as of April 29, 1994:   34,380,000 shares of $1 par
value common stock.

                                   1 of 17

<PAGE>   2
                         PART 1.  FINANCIAL INFORMATION

                VARIAN ASSOCIATES, INC. AND SUBSIDIARY COMPANIES
                      CONSOLIDATED STATEMENTS OF EARNINGS
                                   UNAUDITED

<TABLE>
<CAPTION>
                                        Second Quarter Ended        Six Months Ended
                                      -------------------------  -----------------------
(Dollars in thousands                   April 1,     April 2,      April 1,     April 2,
 except per share amounts)                1994         1993          1994        1993
                                      -----------   ----------   -----------  ----------
<S>                                    <C>          <C>          <C>          <C>
SALES                                  $  394,534   $  325,304   $  718,284   $  616,636
                                       ----------   ----------   ----------   ----------

OPERATING COSTS AND EXPENSES
   Cost of sales                          264,762      216,692      484,407      417,111
   Research and development                21,480       19,137       39,905       36,098
   Marketing                               46,126       44,059       87,833       84,819
   General and administrative              31,523       29,072       55,620       51,027
                                       ----------   ----------   ----------   ----------
   Total operating costs and expenses     363,891      308,960      667,765      589,055
                                       ----------   ----------   ----------   ----------
OPERATING EARNINGS                         30,643       16,344       50,519       27,581

   Interest expense, net                    1,065        1,351        2,127        2,005
                                       ----------   ----------   ----------   ----------
EARNINGS BEFORE TAXES                      29,578       14,993       48,392       25,576

   Taxes on Earnings                       11,240        5,700       18,390        9,720
                                       ----------   ----------   ----------   ----------
NET EARNINGS                           $   18,338   $    9,293   $   30,002   $   15,856
                                       ==========   ==========   ==========   ==========

Average Shares Outstanding Including
Common Stock Equivalents (1)               35,697       36,508       35,742       36,730
                                       ==========   ==========   ==========   ==========

EARNINGS PER SHARE - FULLY DILUTED (1) $     0.51   $     0.25   $     0.84   $     0.43
                                       ==========   ==========   ==========   ==========

- - ----------------------------------------------------------------------------------------
Dividends Declared Per Share (1)       $     0.06   $     0.05   $     0.11   $     0.10

Order Backlog                                                    $  753,500   $  612,200
- - ----------------------------------------------------------------------------------------
</TABLE>





(1) Note: Prior periods restated for two-for-one stock split effected in the
    form of a stock dividend in Q2 FY94.

See accompanying notes to the consolidated financial statements.

                                                                             -2-

                                                       
<PAGE>   3

                VARIAN ASSOCIATES, INC. AND SUBSIDIARY COMPANIES
                       CONSOLIDATED BALANCE SHEETS                          
                                                                         
                                UNAUDITED                               
                                                                         
<TABLE>                                                               
<CAPTION>                                       
                                                                April 1,        October 1,
(Dollars in thousands except par values)                          1994            1993        
<S>                                                                <C>              <C>          
ASSETS
Current Assets
  Cash and cash equivalents                                     $  65,036      $  73,307         
  Accounts receivable                                             325,130        290,513
  Inventories
    Raw materials and parts                                       109,740         89,708 
    Work in process                                                59,988         44,705 
    Finished goods                                                 21,294         27,000 
                                                                ---------     ----------
     Total Inventories                                            191,022        161,413  
   Other current assets                                            68,004         65,793 
                                                                ---------     ----------
    Total Current Assets                                          649,192        591,026 

Property, Plant, and Equipment                                    557,591        544,316                              
  Accumulated depreciation and amortization                      (330,019)      (313,841)
                                                                ---------      ---------
    Net Property, Plant, and Equipment                            227,572        230,475 

Other Assets                                                       52,444         57,506  
                                                                ---------      ---------
    TOTAL ASSETS                                                $ 929,208      $ 879,007
                                                                =========      =========

LIABILITIES AND SHAREHOLDERS' EQUITY
Current Liabilities
  Notes payable                                                 $  49,276      $  22,858
  Accounts payable - trade                                         65,195         58,654
  Accrued expenses                                                210,059        203,848  
  Product warranty                                                 38,801         35,615
  Advance payments from customers                                  65,955         61,282  
                                                                 --------       --------
    Total Current Liabilities                                     429,286        382,257  
Long-Term Debt                                                     60,399         60,470
Deferred Taxes                                                     21,355         21,361   
                                                                 --------       --------
    Total Liabilities                                             511,040        464,088   
                                                                ---------      ---------
Shareholders' Equity
  Preferred stock
    Authorized 1,000,000 shares, par value $1, issued none              -              -           
  Common stock
    Authorized 99,000,000 shares, par value $1, issued and
    outstanding  34,423,000 shares at April 1,1994 and
    34,684,000 shares at October 1, 1993  (1)                      34,423         17,342    
  Retained earnings                                               383,745        397,577
                                                                 --------       --------
    Total Shareholders' Equity                                    418,168        414,919   
                                                                ---------       --------                                 
    TOTAL LIABILITIES AND SHAREHOLDERS' EQUITY                  $ 929,208      $ 879,007                          
                                                                =========      =========             
</TABLE>                                                     


(1)  Outstanding shares have been adjusted on a retroactive basis for the
     two-for-one stock split effected in the form of a stock dividend in Q2
     FY94.

See accompanying notes to the consolidated financial statements.
                                                                             -3-
<PAGE>   4
                VARIAN ASSOCIATES, INC. AND SUBSIDIARY COMPANIES
                CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS
                                   UNAUDITED

<TABLE>
<CAPTION>
                                                                           Six Months Ended
                                                                       ------------------------
                                                                       April 1,        April 2,
(Dollars in thousands)                                                   1994            1993
                                                                      ----------      ----------
<S>                                                                    <C>            <C>
OPERATING ACTIVITIES
       Net Cash Provided by Operating Activities                       $ 14,046        $ 16,397

INVESTING ACTIVITIES
      Purchase of property, plant, and equipment                        (25,563)        (19,235)
      Other, net                                                          3,123          (1,143)
                                                                      ---------       ---------
      Net Cash Used by Investing Activities                             (22,440)        (20,378)

FINANCING ACTIVITIES
      Net borrowings on short-term obligations                           26,418             830
      Proceeds from long-term borrowings                                    -            20,000
      Proceeds from common stock issued to employees                     16,124          12,395
      Purchase of common stock                                          (39,079)        (40,516)
      Other, net                                                         (3,843)         (8,868)
                                                                     ----------       ---------
       Net Cash Used by Financing Activities                               (380)        (16,159)

EFFECTS OF EXCHANGE RATE CHANGES ON CASH                                    503           1,960
                                                                     ----------       ---------
       Net Decrease in Cash and Cash Equivalents                         (8,271)        (18,180)

       Cash and Cash Equivalents at Beginning of Period                  73,307          66,743
                                                                     ----------      ----------
       Cash and Cash Equivalents at End of Period                      $ 65,036        $ 48,563
                                                                     ==========      ==========
</TABLE>





See accompanying notes to the consolidated financial statements.

                                            -4-
<PAGE>   5
                VARIAN ASSOCIATES, INC. AND SUBSIDIARY COMPANIES

                   NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

                                   Unaudited

                             (Dollars in Millions)


NOTE 1:  The consolidated financial statements include the accounts 
         of Varian Associates, Inc. and its subsidiaries and have 
         been prepared by the Company, pursuant to the rules and
         regulations of the Securities and Exchange Commission.  Certain
         information and footnote disclosures normally included in financial
         statements prepared in accordance with generally accepted accounting
         principles have been condensed or omitted pursuant to such rules and
         regulations.  It is suggested that these financial statements be read
         in conjunction with the financial statements and the notes thereto
         included in the Company's latest Form 10-K annual report.  In the
         opinion of management, the consolidated financial statements include
         all normal recurring adjustments necessary to present fairly the
         information required to be set forth therein.  The results of
         operations for the second quarter ended April 1, 1994, and April 2,
         1993 are not necessarily indicative of the results to be expected for
         a full year or for any other periods.

NOTE 2:  Inventories are valued at the lower of cost or market (realizable 
         value) using last-in, first-out (LIFO) cost for the U.S.
         inventories of the Health Care Systems (except for X-Ray Tube
         Products), Instruments, and Semiconductor Equipment segments. All
         other inventories are valued principally at average cost.
         Approximately half of total gross inventories are valued using the
         LIFO method.  If the first-in, first-out (FIFO) method had been used
         for those operations valuing inventories on a LIFO basis, inventories
         would have been higher than reported by $50.8 at  April 1, 1994, $50.8
         at October 1, 1993, and $52.0 at April 2, 1993.

NOTE 3:  The Company enters into forward exchange contracts to mitigate 
         the effects of operational (sales orders and purchase commitments)
         and balance sheet exposures to fluctuations in foreign
         currency exchange rates.  When the Company's foreign exchange
         contracts hedge operational exposure, the effects of movements in
         currency exchange rates on these instruments are recognized in income
         when the related revenue and expenses are recognized.  When foreign
         exchange contracts hedge balance sheet exposure, such effects are
         recognized in income when the exchange rate changes. Because the
         impact of movements in currency exchange rates on foreign exchange
         contracts generally offsets the related impact on the underlying




                                     -5-
<PAGE>   6
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (Continued)

NOTE 3: (Continued)

        items being hedged, these instruments do not subject the Company to
        risk that would otherwise result from changes in currency exchange
        rates.  At April 1, 1994, the Company had forward exchange
        contracts with maturities of twelve months or less to sell foreign
        currencies totalling $64.7 million (3.3 million Canadian dollars,
        4.0 million Swiss francs, 12.1 million Deutsche marks, 6.0 million
        Finnish marks, 97.0 million French Francs, 4.1 million British
        pounds, 8.7 billion Italian lira, 2.2 billion Japanese yen and 20.0
        million Swedish krona) and to buy foreign currencies totalling
        $17.0 million (8.6 million British pounds and 445.0 million
        Japanese yen).


NOTE 4: In November 1992, the Financial Accounting Standards Board issued
        Statement of Financial Accounting Standards (SFAS) 112, Employers'
        Accounting for Postemployment Benefits.  It is effective for the
        Company's fiscal year 1995.  Its adoption will not have a material
        effect on the financial statements of the Company.


NOTE 5: During the  first quarter of fiscal year 1994, the Company  adopted
        SFAS 109, "Accounting for Income Taxes".  Adoption was made on a
        retroactive basis, and resulted in a charge against beginning
        retained earnings at September 28, 1991 of $6.9 million.  The
        audited balance sheet at October 1, 1993 has been restated to
        reflect adoption of this new standard.  Adoption of SFAS 109 did
        not have a material effect on income tax expense, as previously
        reported, for any periods subsequent to fiscal 1991.

        Significant components of deferred tax assets and liabilities as of
        the beginning of fiscal 1994 are as follows:

<TABLE>
           <S>         <C>                           <C>
           Assets:
                       Inventory                     $11.6
                       Product warranty               11.3
                       Deferred compensation           8.6
                       Estimated loss contingencies    6.3
                       Insurance                       3.3
                       Other                           7.3
                                                     -----
                                                     $48.4
                                                     =====
          Liabilities:
                       Depreciation                  $22.0
                       Other                          (0.6)
                                                     -----
                                                     $21.4
</TABLE>                                             =====





                                     -6-

<PAGE>   7
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (Continued)

NOTE 6: On September 21, 1988, Rodney Shields, who purports to be a
        stockholder of the Company, filed a stockholder's derivative action
        in the Superior Court of the State of California, County of Santa
        Clara.  The complaint alleged that the Company obtained certain
        defense contracts by illegal means, overcharged the government in
        connection with other defense contracts, and  that certain named
        individuals, including 17 present or former directors or officers
        of the Company, breached their fiduciary duties.  On November 2,
        1993, the California Court of Appeal issued a writ of mandate
        directing entry of summary judgment in favor of all defendants.
        Mr. Shields did not seek further judicial review of that writ, and
        a judgment of dismissal was entered by the Superior Court on
        December 27, 1993.

        In February 1990 a purported class action was brought by Panache
        Broadcasting of Pennsylvania, Inc. on behalf of all purchasers of
        electron tubes in the U.S. against the Company and a joint-venture
        partner, alleging that the activities of their joint venture in the
        power-grid tube industry violated antitrust laws.  The complaint
        seeks injunctive relief and unspecified damages which may be
        trebled under the antitrust laws.  In February 1993, the U.S.
        District Court in Chicago granted the Company's motion to dismiss
        the complaint with leave to amend.  Panache Broadcasting filed an
        amended complaint in March 1993.  The Company has moved to dismiss
        that complaint.  No determination has been made regarding the
        plaintiffs' request to certify the purported class.  The Company
        believes that it has meritorious defenses to the Panache lawsuit.

        In addition to the above-referenced matters, the Company is
        currently a defendant in a number of legal actions and could incur
        an uninsured liability in one or more of them.  In the opinion of
        management, the outcome of the above litigation will not have a
        material adverse effect on the financial condition of the Company.

        The Company has also been named by the U.S. Environmental
        Protection Agency or third parties as a potentially responsible
        party under the Comprehensive Environmental Response Compensation
        and Liability Act of 1980, as amended, at six sites to which Varian
        is alleged to have shipped manufacturing waste for disposal.  The
        Company is also involved in various stages of environmental
        investigation and/or remediation under the direction of, or in
        consultation with, local and/or state agencies at certain current
        or former Company facilities.





                                     -7-

<PAGE>   8
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (Continued)

NOTE 6: (Continued)

        Uncertainty as to (a) the extent to which the Company caused, if at
        all, the condition being investigated, (b) the extent of
        environmental contamination and risks, (c) the applicability of
        changing and complex environmental laws, (d) the number and
        financial viability of other potentially responsible parties,   
        (e) the stage of the investigation and/or remediation, (f) the
        unpredictability of investigation and/or remediation costs
        (including as to when they will be incurred), (g) applicable
        clean-up standards, (h) the remediation (if any) which will
        ultimately be required, and (i) available technology make it
        difficult to assess the likelihood and scope of further
        investigation or remediation activities or to estimate the future
        costs of such activities if undertaken.  In addition, the Company
        believes that it has rights to contribution and/or reimbursement
        from financially viable, potentially responsible parties and/or
        insurance companies, and has filed a lawsuit against 36 insurance
        companies with respect to most of the above-referenced sites.  The
        Company has established reserves for these environmental matters,
        which reserves management believes are adequate.  Based on
        information currently available, management believes that the costs
        of these matters are otherwise not reasonably likely to have a
        material adverse effect on the financial condition of the Company.


NOTE 7: All share and per share information has been restated to reflect a
        two-for-one stock split, effected in the form of a stock dividend,
        which was distributed in March 1994.





                                     -8-

<PAGE>   9
                    MANAGEMENT'S DISCUSSION AND ANALYSIS OF
                 FINANCIAL CONDITION AND RESULTS OF OPERATIONS


On April 21, Varian reported significantly higher orders, sales
and profits for the second quarter and first half of 1994 from
last year's comparable periods. Earnings per share also increased
in the second quarter, reaching $0.51 (adjusted for the 2-for-1
stock split distributed in March 1994) from $0.25 a year ago.

Net earnings for the quarter increased 97% to $18.3 million from
$9.3 million in the year-ago period.  Orders of $413 million rose
29% over last year's $319 million.  Second quarter sales totaled
$395 million, versus $325 million of a year ago.  Backlog of $754
million was up 23% over the prior year.

In the first six months of 1994, Varian had net earnings of $30
million ($0.84 per share) which nearly doubled the prior year's
$15.9 million ($0.43 per share).  First-half orders reached  $853
million compared to 1993's $661 million.  Sales rose to $718
million, from $617 million in 1993.

First-half orders continued to grow, with all four core businesses
contributing to this growth and experiencing higher profitability
during the quarter as well as the first six months of 1994.

Orders for Health Care Systems rose 16% for the half year, as the
business posted its fourth straight quarter of over $100 million
in bookings. First-half sales advanced 8%, pushing backlog to $297
million.  The business also achieved better operating margins
relative to the year-ago period.

Demand for Varian's cancer therapy equipment remains strong, both
domestically and internationally.  This reflects growing
appreciation of the cost-effectiveness of radiation therapy as
well as the enhanced treatment capabilities of Varian's products.
Orders for X-ray tube products also rose.

Instruments' orders registered a 13% gain during the second
quarter, and were up modestly from the first-half.  Sales and
profits were also ahead of 1993 levels, while backlog rose 27%
over the prior year's mid-point.

The increase in Instruments' orders was led by the nuclear
magnetic resonance instrument business and the revitalized vacuum
products operation.   New instruments and accessories designed to
match customer needs in several diverse markets also contributed
to the higher business levels.



                                     -9-

<PAGE>   10
MANAGEMENT'S DISCUSSION AND ANALYSIS (continued)


Semiconductor Equipment orders rose to $306 million during the
first six months.  Sales were 71% ahead of the year-ago period.
Backlog rose for the fourth quarter in a row, increasing 119% over
the prior year period to $193 million.  Some moderation in demand
is likely during the second-half of fiscal 1994.

First-half orders for the Electron Devices business were slightly
ahead of last year, while sales and backlog were modestly lower.
Aggressive downsizing in this business over the last several years
has allowed improved operating margins despite slow market
conditions.

In November 1992, the FASB issued SFAS 112, Employer's Accounting
for Postemployment Benefits.  It is effective for  the Company's
fiscal year 1995.  Its adoption will not have a material effect on
the financial statements of the Company.


FINANCIAL CONDITION

The Company's financial condition remained strong during the first
six months of fiscal 1994.  Operating activities provided  $14.1
million in the first-half of fiscal 1994 compared to $16.4 million
in the same period last year.  Investing activities used $22.4
million and $20.4 million in the first half of fiscal years 1994
and 1993, respectively, mainly for the purchase of property,
plant, and equipment.  Financing activities used cash of $0.4
million in the first half of fiscal year 1994, compared to $16.2
million in the same period last year.  Net borrowings of $26.4
million increased total debt as a percentage of total capital to
20.8% at the end of the second quarter of fiscal year 1994 as
compared with 16.7% at the end of fiscal year 1993.  The ratio of
current assets to current liabilities decreased slightly to 1.51
at April 2, 1994, from 1.55 at fiscal year end, 1993.  The Company
has available $50 million in unused lines of credit.


OUTLOOK

Despite the favorable financial results described above, future
revenue and profitability remain difficult to predict.  The
Company continues to face various risks associated with its
business operations including uncertain general worldwide economic
conditions, lingering worldwide recessionary conditions
(particularly in Europe and Japan), and uncertainty regarding
proposed legislation and private initiatives in the U.S. to
control health care costs.  Such conditions could affect the
Company's future performance.





                                     -10-

<PAGE>   11
MANAGEMENT'S DISCUSSION AND ANALYSIS (continued)


As discussed in the Annual Report Form 10-K for the fiscal year
ended October 1, 1993, the Company is involved in certain
environmental matters.  The Company has established reserves for
these environmental  matters, which reserves management believes
are adequate.  Based on information currently available,
management continues to believe that the costs of these matters,
individually or in the aggregate, are otherwise not reasonably
likely to have a material adverse effect on the financial
condition or results of operations of the Company.


                                     -11-

<PAGE>   12
                       REPORT OF INDEPENDENT ACCOUNTANTS




To the Board of Directors of Varian Associates, Inc.:


We have reviewed the consolidated balance sheet of Varian Associates,
Inc. and subsidiary companies as of April 1, 1994, and the related
consolidated statements of earnings and the condensed consolidated
statements of cash flows for the quarters and semi-annual periods ended
April 1, 1994 and  April 2, 1993.  These financial statements are the
responsibility of the Company's management.

We conducted our review in accordance with standards established by the
American Institute of Certified Public Accountants.  A review of interim
financial information consists principally of applying analytical
procedures to financial data and making inquiries of persons responsible
for financial and accounting matters. It is substantially less in scope
than an audit conducted in accordance with generally accepted auditing
standards, the objective of which is the expression of an opinion
regarding the financial statements taken as a whole.  Accordingly, we do
not express such an opinion.

Based on our review, we are not aware of any material modifications that
should be made to the aforementioned financial statements for them to be
in conformity with generally accepted accounting principles.



                                          /s/ Coopers  Lybrand
                                              COOPERS  LYBRAND

San Jose, California
April 20, 1994





                                     -12-

<PAGE>   13
PART II.   OTHER INFORMATION


Item 4     Submission of Matters to a Vote of Security Holders

At the Company's Annual Meeting of Stockholders held on February 17, 1994,
the stockholders of the Company voted on the election of five directors to
the Company's Board of Directors for three-year terms.  The voting on each
such nominee for director was as follows:

<TABLE>
<CAPTION>
                       Votes        Votes        Votes                  Broker
Nominee                For        Against      Withheld  Abstentions  Nonvotes1
<S>                   <C>            <C>       <C>          <C>
Ruth M. Davis         13,785,781     0         34,842        0
David W. Martin, Jr.  13,699,279     0         34,842        0
J. Tracy O'Rourke     13,785,322     0         34,842        0
Donald O. Pederson    13,792,089     0         34,842        0
Richard W. Vieser     13,785,711     0         34,842        0
</TABLE>

1 Pursuant to the Rules of the New York Stock Exchange, this election of
  directors constituted a routine matter, and therefore brokers were
  permitted to vote without receipt of instructions from clients.


Item 6    Exhibits and Reports on Form 8-K

(a)       Exhibit 11-Computation of Earnings Per Share.

(b)       Exhibit 15-Letter Regarding Unaudited Interim Financial
          Information.

(c)       Reports on Form 8-K:

          There were no reports on Form 8-K filed for the second 
          quarter ended April 1, 1994.


                                     -13-
<PAGE>   14

                                   SIGNATURE


Pursuant to the requirements of the Securities Exchange Act of 1934, the
Registrant has duly caused this report to be signed on its behalf by the
undersigned thereunto duly authorized.



                                            VARIAN ASSOCIATES, INC.
                                         ------------------------------
                                                   Registrant


                                                  May 12, 1994
                                         ------------------------------
                                                      Date


                                              /s/ Wayne P. Somrak
                                         ------------------------------  
                                                  Wayne P. Somrak
                                          Vice President and Controller





                                     -14-


<PAGE>   15
                               INDEX OF EXHIBITS


<TABLE>
<CAPTION>
  Exhibit
  Number                                                                     Page
- - ----------                                                                ---------
<S>             <C>                                                       <C>
     11         Computation of Earnings Per Share                              16

     15         Letter Regarding Unaudited Interim Financial Information       17
</TABLE>





                                                               -15-

<PAGE>   1


                                                                      EXHIBIT 11
                COMPUTATION OF EARNINGS PER SHARE IN ACCORDANCE
                     WITH INTERPRETIVE RELEASE NO. 34-9083
                                   UNAUDITED

<TABLE>

                                                               Second Quarter Ended        Six Months Ended
                                                                Apr 1,       Apr 2,       Apr 1,      Apr 2,
(Shares in Thousands)                                            1994         1993         1994        1993
<S>                                                             <C>          <C>          <C>        <C>
Actual weighted average shares outstanding 
  for the period (1)                                            34,486       35,662       34,522      35,866

Dilutive employee stock options (1)                              1,211          846        1,220         864

Weighted average shares outstanding for 
  the period (1)                                                35,697       36,508       35,742      36,730


(Dollars in thousands, except per share amounts)

Earnings applicable to fully diluted earnings per share       $ 18,338     $  9,293     $ 30,002    $ 15,856

Earnings per share based on SEC interpretive release
  No. 34-9083:

Earnings per share - Fully Diluted  (1) (2)                   $   0.51    $    0.25     $   0.84    $   0.43
</TABLE>

(1) Prior periods restated for two-for-one stock split effected in the form of
    a stock dividend in March 1994.
(2) There is no significant difference between fully diluted earnings per share
    and primary earnings per share.



                                     -16-








<PAGE>   1
                                                                     Exhibit  15


Securities and Exchange Commission
450 Fifth Street, N.W.
Washington, D.C.  20549

       
      RE: Varian Associates, Inc.
          Registrations on Forms S-8 and S-3


We are aware that our report dated April 20, 1994 on our review of the
interim financial information of Varian Associates, Inc. for the quarter
ended April 1, 1994 included in this Form 10-Q is incorporated by
reference in the Company's registration statements on  Forms S-8,
Registration Statement Numbers 33-46000, 33-33661, 33-33660, and 2-95139
and Forms S-8 and S-3, Registration Statement Number 33-40460.  Pursuant
to Rule 436(c) under the Securities Act of 1933 this report should not be
considered a part of the registration statements prepared or certified by
us within the meaning of Sections 7 and 11 of that Act.




                                        /s/ Coopers & Lybrand 
                                       ---------------------------
                                            COOPERS & LYBRAND        



San Jose, California
May 11, 1994





                                     -17-



© 2022 IncJournal is not affiliated with or endorsed by the U.S. Securities and Exchange Commission